Advertisement
Screener

Quince Therapeutics, Inc. (QNCX) Auditor

Quince Therapeutics, Inc. Auditor

The independent registered public accounting firm that signed the audit report in each annual report on Form 10-K, newest first. PCAOB firm ID and the internal-control attestation are as tagged on the cover from fiscal 2021; earlier rows come from the signed report text.

  • 2026-04-10: Fiscal year end 2025-12-31; Auditor BDO USA, P.C.; PCAOB firm ID 243; Location San Jose, California.
  • 2025-03-24: Fiscal year end 2024-12-31; Auditor BDO USA, P.C.; PCAOB firm ID 243; Location San Jose, CaliforniaMarch 24, 2025.
  • 2024-04-01: Fiscal year end 2023-12-31; Auditor BDO USA, P.C.; PCAOB firm ID 243; Location San Jose, California.
  • 2023-03-15: Fiscal year end 2022-12-31; Auditor BDO USA, LLP; PCAOB firm ID 243; Location San Jose, California.
FiledFiscal year endAuditorPCAOB firm IDLocationInternal-control attestation
2026-04-102025-12-31BDO USA, P.C.243San Jose, CaliforniaNo
2025-03-242024-12-31BDO USA, P.C.243San Jose, CaliforniaMarch 24, 2025No
2024-04-012023-12-31BDO USA, P.C.243San Jose, CaliforniaNo
2023-03-152022-12-31BDO USA, LLP243San Jose, CaliforniaNo
2022-03-012021-12-31BDO USA, LLP243San Jose, CaliforniaYes
2021-03-012020-12-31BDO USA, LLPSan Jose, CaliforniaYes
2020-03-162019-12-31BDO USA, LLPSan Jose, California

Similar stocks

Stock NameCountryMarket CapPE Ratio
CEL SCI CORP (CVM)United States$0.030B-0.81
aTYR PHARMA INC (ATYR)United States$0.033B-0.98
Estrella Immunopharma, Inc. (ESLA)United States$0.020B
Scilex Holding Co (SCLX)United States$0.042B-0.14
Jasper Therapeutics, Inc. (JSPR)United States$0.020B-0.37
Metagenomi Therapeutics, Inc. (MGX)United States$0.044B-0.48
BioCardia, Inc. (BCDA)United States$0.016B
DYADIC INTERNATIONAL INC (DYAI)United States$0.016B
Passage BIO, Inc. (PASG)United States$0.015B-0.43
LeonaBio, Inc. (LONA)United States$0.047B-0.61